This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Cough Suppressants Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Type (Dextromethorphan, Codeine, Noscapine, Others); Form (Tablet/Pill, Syrup, Inhalers, Others); End User (Hospitals, Clinics, Others) and Geography
Cough is a prevalent symptom of various upper and lower respiratory tract infections. It is a reflex response to mechanical, chemical, or inflammatory irritation of the tracheobronchial tree, which is conveyed by sensory neurons in the airways reflexly through neurons present in the brainstem. Antitussives, also known as cough suppressants, are widely used to relieve the symptoms of cough. The cough suppressant works by reducing the activity of cough reflex and suppresses the urge to cough. Dextromethorphan and Codeine are the two most common cough suppressant drugs widely used in the treatment of cough.
MARKET DYNAMICS
The cough suppressants market has shown a significant evolution over the forecast period. The rise of the cough suppressants market is majorly driven by the vulnerable indoor and outdoor allergens and improvement in treatment. High cases of cough hypersensitivity syndrome associated with Gastroesophageal Reflux Disease (GERD) also act as a positive indicator for the rise in market growth. Moreover, according to the data published by the National Center for Biotechnology Information in 2014, cough is the most common reason for visits to primary care physicians globally, accounting for around 8% of all consultations. According to the same source, the annual prevalence of cough in the general population is approximately 10-33% globally. However, some stringent regulations against cough suppressant drugs are expected to hinder the global cough suppressants market growth during the forecast period. For instance, in January 2020, the FDA introduced a regulation that inhibits the use of codeine-based cough suppressant drugs in children less than 18 years of age.
MARKET SCOPE
The "Cough Suppressants Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, with a specific focus on the global market trend analysis. This report provides an outline of the cough suppressants market with detailed market segmentation by drug type, form, and end-user. The cough suppressants market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the cough suppressants market and offers key opportunities and trends.
MARKET SEGMENTATION
The market is categorized based on the drug type, form, and end user. Based on the drug type, the market is segmented as dextromethorphan, codeine, noscapine, and others. Based on the form, the segmentation of the market is into tablet/pill, syrup, inhalers, and others. Based on end user, segmentation of the market is into hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report states a comprehensive outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the cough suppressants market based on various segments. The report also comprises market size and forecast estimates from the year 2020 to2028with respect to five primary regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East, and Africa (MEA), and South & Central America (SCAM). The cough suppressants market by each region is then sub-segmented into respective countries and segments. It provides the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the cough suppressants market from both the demand and supply sides. Moreover, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after assessing political, social, economic, and technological factors affecting the cough suppressants market in these regions.
Get more information on this report :
MARKET PLAYERS
The report contains critical developments in the cough suppressants market as inorganic and organic growth strategies. Multiple companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Many such activities have paved the path for elaborating the business and customer base of market players. The market players from the cough suppressants market are estimated to have profitable growth opportunities in the coming years, with a higher demand for cough suppressants in the global market. Mentioned below is the list of a few companies engaged in the cough suppressants market.
The report also provides key players' profiles in the cough suppressants market, along with their SWOT analysis and market strategies. Moreover, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
Pfizer Inc.
Atley Pharmaceuticals, Inc.
Novartis International AG
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd
AstraZeneca
Sanofi
Sun Pharmaceutical Industries Ltd.
3M
Teva Pharmaceuticals Industries Ltd
The Insight Partner's dedicated research and the analytical team consists of experienced professionals with advanced statistical expertise and provides various customization options in the current study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cough Suppressants Market - By Drug Type
1.3.2 Cough Suppressants Market - By Form
1.3.3 Cough Suppressants Market - By End User
1.3.4 Cough Suppressants Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COUGH SUPPRESSANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
6. COUGH SUPPRESSANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. COUGH SUPPRESSANTS - GLOBAL MARKET OVERVIEW
6.2. COUGH SUPPRESSANTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. COUGH SUPPRESSANTS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. DEXTROMETHORPHAN
7.3.1. Overview
7.3.2. Dextromethorphan Market Forecast and Analysis
7.4. CODEINE
7.4.1. Overview
7.4.2. Codeine Market Forecast and Analysis
7.5. NOSCAPINE
7.5.1. Overview
7.5.2. Noscapine Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. COUGH SUPPRESSANTS MARKET - REVENUE AND FORECASTS TO 2028 - FORM
8.1. OVERVIEW
8.2. FORM MARKET FORECASTS AND ANALYSIS
8.3. TABLET/PILL
8.3.1. Overview
8.3.2. Tablet/Pill Market Forecast and Analysis
8.4. SYRUP
8.4.1. Overview
8.4.2. Syrup Market Forecast and Analysis
8.5. INHALERS
8.5.1. Overview
8.5.2. Inhalers Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. COUGH SUPPRESSANTS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. COUGH SUPPRESSANTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cough Suppressants Market Overview
10.1.2 North America Cough Suppressants Market Forecasts and Analysis
10.1.3 North America Cough Suppressants Market Forecasts and Analysis - By Drug Type
10.1.4 North America Cough Suppressants Market Forecasts and Analysis - By Form
10.1.5 North America Cough Suppressants Market Forecasts and Analysis - By End User
10.1.6 North America Cough Suppressants Market Forecasts and Analysis - By Countries
10.1.6.1 United States Cough Suppressants Market
10.1.6.1.1 United States Cough Suppressants Market by Drug Type
10.1.6.1.2 United States Cough Suppressants Market by Form
10.1.6.1.3 United States Cough Suppressants Market by End User
10.1.6.2 Canada Cough Suppressants Market
10.1.6.2.1 Canada Cough Suppressants Market by Drug Type
10.1.6.2.2 Canada Cough Suppressants Market by Form
10.1.6.2.3 Canada Cough Suppressants Market by End User
10.1.6.3 Mexico Cough Suppressants Market
10.1.6.3.1 Mexico Cough Suppressants Market by Drug Type
10.1.6.3.2 Mexico Cough Suppressants Market by Form
10.1.6.3.3 Mexico Cough Suppressants Market by End User
10.2. EUROPE
10.2.1 Europe Cough Suppressants Market Overview
10.2.2 Europe Cough Suppressants Market Forecasts and Analysis
10.2.3 Europe Cough Suppressants Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Cough Suppressants Market Forecasts and Analysis - By Form
10.2.5 Europe Cough Suppressants Market Forecasts and Analysis - By End User
10.2.6 Europe Cough Suppressants Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cough Suppressants Market
10.2.6.1.1 Germany Cough Suppressants Market by Drug Type
10.2.6.1.2 Germany Cough Suppressants Market by Form
10.2.6.1.3 Germany Cough Suppressants Market by End User
10.2.6.2 France Cough Suppressants Market
10.2.6.2.1 France Cough Suppressants Market by Drug Type
10.2.6.2.2 France Cough Suppressants Market by Form
10.2.6.2.3 France Cough Suppressants Market by End User
10.2.6.3 Italy Cough Suppressants Market
10.2.6.3.1 Italy Cough Suppressants Market by Drug Type
10.2.6.3.2 Italy Cough Suppressants Market by Form
10.2.6.3.3 Italy Cough Suppressants Market by End User
10.2.6.4 Spain Cough Suppressants Market
10.2.6.4.1 Spain Cough Suppressants Market by Drug Type
10.2.6.4.2 Spain Cough Suppressants Market by Form
10.2.6.4.3 Spain Cough Suppressants Market by End User
10.2.6.5 United Kingdom Cough Suppressants Market
10.2.6.5.1 United Kingdom Cough Suppressants Market by Drug Type
10.2.6.5.2 United Kingdom Cough Suppressants Market by Form
10.2.6.5.3 United Kingdom Cough Suppressants Market by End User
10.2.6.6 Rest of Europe Cough Suppressants Market
10.2.6.6.1 Rest of Europe Cough Suppressants Market by Drug Type
10.2.6.6.2 Rest of Europe Cough Suppressants Market by Form
10.2.6.6.3 Rest of Europe Cough Suppressants Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cough Suppressants Market Overview
10.3.2 Asia-Pacific Cough Suppressants Market Forecasts and Analysis
10.3.3 Asia-Pacific Cough Suppressants Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Cough Suppressants Market Forecasts and Analysis - By Form
10.3.5 Asia-Pacific Cough Suppressants Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Cough Suppressants Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cough Suppressants Market
10.3.6.1.1 Australia Cough Suppressants Market by Drug Type
10.3.6.1.2 Australia Cough Suppressants Market by Form
10.3.6.1.3 Australia Cough Suppressants Market by End User
10.3.6.2 China Cough Suppressants Market
10.3.6.2.1 China Cough Suppressants Market by Drug Type
10.3.6.2.2 China Cough Suppressants Market by Form
10.3.6.2.3 China Cough Suppressants Market by End User
10.3.6.3 India Cough Suppressants Market
10.3.6.3.1 India Cough Suppressants Market by Drug Type
10.3.6.3.2 India Cough Suppressants Market by Form
10.3.6.3.3 India Cough Suppressants Market by End User
10.3.6.4 Japan Cough Suppressants Market
10.3.6.4.1 Japan Cough Suppressants Market by Drug Type
10.3.6.4.2 Japan Cough Suppressants Market by Form
10.3.6.4.3 Japan Cough Suppressants Market by End User
10.3.6.5 South Korea Cough Suppressants Market
10.3.6.5.1 South Korea Cough Suppressants Market by Drug Type
10.3.6.5.2 South Korea Cough Suppressants Market by Form
10.3.6.5.3 South Korea Cough Suppressants Market by End User
10.3.6.6 Rest of Asia-Pacific Cough Suppressants Market
10.3.6.6.1 Rest of Asia-Pacific Cough Suppressants Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Cough Suppressants Market by Form
10.3.6.6.3 Rest of Asia-Pacific Cough Suppressants Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cough Suppressants Market Overview
10.4.2 Middle East and Africa Cough Suppressants Market Forecasts and Analysis
10.4.3 Middle East and Africa Cough Suppressants Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Cough Suppressants Market Forecasts and Analysis - By Form
10.4.5 Middle East and Africa Cough Suppressants Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Cough Suppressants Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cough Suppressants Market
10.4.6.1.1 South Africa Cough Suppressants Market by Drug Type
10.4.6.1.2 South Africa Cough Suppressants Market by Form
10.4.6.1.3 South Africa Cough Suppressants Market by End User
10.4.6.2 Saudi Arabia Cough Suppressants Market
10.4.6.2.1 Saudi Arabia Cough Suppressants Market by Drug Type
10.4.6.2.2 Saudi Arabia Cough Suppressants Market by Form
10.4.6.2.3 Saudi Arabia Cough Suppressants Market by End User
10.4.6.3 U.A.E Cough Suppressants Market
10.4.6.3.1 U.A.E Cough Suppressants Market by Drug Type
10.4.6.3.2 U.A.E Cough Suppressants Market by Form
10.4.6.3.3 U.A.E Cough Suppressants Market by End User
10.4.6.4 Rest of Middle East and Africa Cough Suppressants Market
10.4.6.4.1 Rest of Middle East and Africa Cough Suppressants Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa Cough Suppressants Market by Form
10.4.6.4.3 Rest of Middle East and Africa Cough Suppressants Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cough Suppressants Market Overview
10.5.2 South and Central America Cough Suppressants Market Forecasts and Analysis
10.5.3 South and Central America Cough Suppressants Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Cough Suppressants Market Forecasts and Analysis - By Form
10.5.5 South and Central America Cough Suppressants Market Forecasts and Analysis - By End User
10.5.6 South and Central America Cough Suppressants Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cough Suppressants Market
10.5.6.1.1 Brazil Cough Suppressants Market by Drug Type
10.5.6.1.2 Brazil Cough Suppressants Market by Form
10.5.6.1.3 Brazil Cough Suppressants Market by End User
10.5.6.2 Argentina Cough Suppressants Market
10.5.6.2.1 Argentina Cough Suppressants Market by Drug Type
10.5.6.2.2 Argentina Cough Suppressants Market by Form
10.5.6.2.3 Argentina Cough Suppressants Market by End User
10.5.6.3 Rest of South and Central America Cough Suppressants Market
10.5.6.3.1 Rest of South and Central America Cough Suppressants Market by Drug Type
10.5.6.3.2 Rest of South and Central America Cough Suppressants Market by Form
10.5.6.3.3 Rest of South and Central America Cough Suppressants Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. COUGH SUPPRESSANTS MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ATLEY PHARMACEUTICALS, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS INTERNATIONAL AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK & CO., INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANOFI
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SUN PHARMACEUTICAL INDUSTRIES LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. 3M
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICALS INDUSTRIES LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Pfizer Inc.
2. Atley Pharmaceuticals, Inc.
3. Novartis International AG
4. Merck & Co., Inc.
5. F. Hoffmann-La Roche Ltd
6. AstraZeneca
7. Sanofi
8. Sun Pharmaceutical Industries Ltd.
9. 3M
10. Teva Pharmaceuticals Industries Ltd
